Singleron Biotechnologies
Nanjing, China · Founded 2018 · $140.0M raised
- Headquarters
- Nanjing
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- singleron.bio
- Total Funding
- $140.0M
- Last Round
- $100.0M Series BNov 2021
- Rounds
- 4
About
Single-cell multi-omics solutions company advancing precision medicine with end-to-end sequencing platforms.
Summary
Singleron Biotechnologies is a Biotech company based in Nanjing, China, founded in 2018. It has raised $140.0M in total across 4 rounds, most recently a $100.0M Series B round in Nov 2021. Investors include Lilly Asia Ventures, Lake Bleu Capital and MSA Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...